ETH
REGN icon

Exos TFP Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History

Exos TFP Holdings’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,794
Closed -$1.47M – 373
2023
Q1 		$1.47M Buy
1,794
+942
+111% +$710K 0.37% 87
2022
Q4 		$615K Sell
852
-50
-6% -$36.9K 0.17% 141
2022
Q3 		$621K Buy
+902
New +$568K 0.28% 107

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Exos TFP Holdings's REGN Position: Q2 2023 in Review

Exos TFP Holdings sold out of Regeneron Pharmaceuticals (REGN) in Q2 2023, closing a stake of 1,794 shares — an estimated $1.47M sold.

Exos TFP Holdings first reported a position in REGN in Q3 2022 and held it in 3 quarters. The position peaked at $1.47M in Q1 2023. 1,164 funds tracked by Wall St. Rank hold REGN as of Q2 2023.

  • Exos TFP Holdings reported no remaining Regeneron Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Exos TFP Holdings sold 1,794 Regeneron Pharmaceuticals shares in Q2 2023, an estimated $1.47M.
  • Exos TFP Holdings first reported a position in Regeneron Pharmaceuticals in Q3 2022 and held it in 3 quarters.
  • Exos TFP Holdings's Regeneron Pharmaceuticals position peaked at $1.47M in Q1 2023.
  • 1,164 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2023.

Based on Exos TFP Holdings's 13F filing for Q2 2023, filed 14 Aug 2023.